10.6084/m9.figshare.5938018.v1 V. Gnanapragasam V. Gnanapragasam O. Bratt O. Bratt K. Muir K. Muir L. Lee L. Lee H. Huang H. Huang P. Stattin P. Stattin A. Lophatananon A. Lophatananon Additional file 7: of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study Springer Nature 2018 Prostate cancer Prognostic prediction Cancer-specific mortality Cambridge Prognostic Groups Non-metastatic disease Stratification All-cause mortality Competing risks Improved treatment section Treatment selection 2018-02-28 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_7_of_The_Cambridge_Prognostic_Groups_for_improved_prediction_of_disease_mortality_at_diagnosis_in_primary_non-metastatic_prostate_cancer_a_validation_study/5938018 Table S7. Distribution of cases and deaths from prostate cancer and hazard ratios for each Cambridge Prognostic Group (CPG) in the PCBaSe radical radiotherapy cohort (n = 11,872). (DOCX 15 kb)